SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 29th, 2021 • Todos Medical Ltd. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 11, 2021, between Todos Medical Ltd., a corporation organized under the laws of Israel (the “Company”), and T-Cell Protect Hellas S.A. (the “Purchaser”).
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC PharmaTodos Medical Ltd. • November 29th, 2021 • Surgical & medical instruments & apparatus
● Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as Tollovir that utilize the 3CL protease related IP
LICENSE AGREEMENTLicense Agreement • November 29th, 2021 • Todos Medical Ltd. • Surgical & medical instruments & apparatus • New York
THIS LICENSE AGREEMENT is made and entered into as of November 1, 2021, (the “Effective Date”) by and between Todos Medical Ltd.’s (“TOMDF”) wholly-owned subsidiary 3CL Sciences, Inc., a corporation of the State of Nevada, currently having its principal place of business at 40 Wall Street, Suite 2702, New York, NY 10005 (hereinafter referred to as “TCLS”), and T-Cell Protect Hellas S.A., a corporation of the State of Greece, having its principal place of business at 5 Mimnermou Street, Athens, Greece1070, (hereinafter referred to as “T-CELL”)
